Rana Lonnen

Rana Lonnen serves as the Managing Director of dRx Capital at Novartis since May 2017 and holds the position of Head S&E Strategic Venture Capital at Yseop as of October 2023. Additionally, Rana Lonnen is involved as an Investor and Board Observer for multiple companies, including Lightship, Octave, RxLightning Inc., Holmusk, H1, Koneksa, and Mekonos Inc., all within various periods from May 2021 to the present. Rana Lonnen also contributes as a Board Observer for COTA, Inc. Educational qualifications include an MBA from Imperial College London (2015-2016) and a PhD in Molecular Biology from the University of Leicester (1999-2003).